No Data
No Data
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
12 Health Care Stocks Moving In Friday's Pre-Market Session
Express News | Accuray Incorporated Reports Inducement Award Under Nasdaq Listing Rules
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Stockholders Approve Plans and Appoint New Officer
Roth MKM Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $7
No Data
No Data